Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Feridex labeling changes "not approvable"

This article was originally published in Pharmaceutical Approvals Monthly

Executive Summary

Advanced Magnetic's sNDA for Feridex I.V. provides "insufficient" data, FDA says in an Aug. 27 "not approvable" letter. The firm was seeking rapid infusion dosing and labeling claims regarding the characterization of liver lesions as benign or malignant. The contrast agent was approved in 1996 for use with MRI to aid in the detection and evaluation of liver lesions
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS001592

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel